Retracted: Expression of proliferating cell nuclear antigen and Ki-67 in renal cell carcinoma in eastern Indian patients

Sandip Pramanik; Subhayan Sur; Biswabandhu Bankura; Chinmay Kumar Panda; Dilip Kumar Pal

doi:10.18203/2349-2902.isj20194425

Authors

Sandip Pramanik Department of Urology, IPGMER, Kolkata, West Bengal, India
Subhayan Sur Department of Pathology, Saint Louis University, USA
Biswabandhu Bankura Department of Oncogene Regulation, CNCI, Kolkata, West Bengal, India
Chinmay Kumar Panda Department of Oncogene Regulation, CNCI, Kolkata, West Bengal, India
Dilip Kumar Pal Department of Urology, IPGMER, Kolkata, West Bengal, India

DOI:

https://doi.org/10.18203/2349-2902.isj20194425

Keywords:

PCNA, Ki-67, Renal cell carcinoma

Abstract

The article "Expression of proliferating cell nuclear antigen and Ki-67 in renal cell carcinoma in eastern Indian patients" is retracted by the Editor-in-Chief, due to evidence of image duplication and data overlap. The reliability of the findings in this article is compromised.

The authors were notified of this retraction.

Metrics

Metrics Loading ...

References

Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin. 1999;49:8-31.

Yuan ZX, Mo J, Zhao G, Shu G, Fu HL, Zhao W, Targeting strategies for renal cell carcinoma:from renal cancer cells to renal cancer stem cells. Front Pharmacol. 2016;7:1-15.

Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11-30.

Cook A, Lorenzo AJ, Salle JL, Bakhshi M, Cartwright LM, Bagi D, et al. Pediatric renal cell carcinoma:single institution 25-year case series and initial experience with partial nephrectomy. J Urol. 2006;175:1456-60.

Störkel S. Classification of renal cancer: Correlation of morphology and cytogenetics. Vogelzang NJ Scardino PT, Shipley WU, Coffey DS, eds. Comprehensive textbook of genitourinary oncology. 2nd ed. Williams & Wilkins Baltimore. 1996: 179-186.

Procopio, G, Verzoni, E, Iacovelli, R, Biasoni, D, Testa, I, Porcu, L, et al. Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies. Br J Cancer. 2012;107(8):1227-32.

Volpe A, Patard JJ. Prognostic factors in renal cell carcinoma. World J Urol. 2010;28:319-27.

Moldovan GL, Pfander B, Jentsch S. PCNA, the maestro of the replication fork. Cell. 2007;129:665-79.

Warbrick E. PCNA binding through a conserved motif. BioEssays. 1998;20:195-9.

Gilljam KM, Feyzi E, Aas PA, Sousa MM, Müller R, Vågbø CB, et al. Identification of a novel, widespread, and functionally important PCNA-binding motif. J Cell Biol. 2009;186:645-54.

Mailand N, Gibbs-Seymour I, Bekker-Jensen S. Regulation of PCNA-protein interactions for genome stability. Nature reviews. Molecular Cell Biol. 2013;14:269-82.

Schönenberger F, Deutzmann A, Ferrando-May E, Merhof D. Discrimination of cell cycle phases in PCNA-immunolabeled cells. BMC Bioinform. 2015;16:180.

Wang SC. PCNA: a silent housekeeper or a potential therapeutic target. Trends Pharmacol Sci. 2014;35:178-86.

Schonk DM, Kuijpers HJ, van Drunen E, van Dalen CH, Geurts van Kessel AH, Verheijen R, et al. Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10. Hum Genet. 1989;83:297-9.

Bullwinkel J, Baron-Lühr B, Lüdemann A, Wohlenberg C, Gerdes J, Scholzen T. Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol. 2006;206:624-35.

Rahmanzadeh R, Hüttmann G, Gerdes J, Scholzen T. Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis. Cell Prolif. 2007;40:422-30.

Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311-22.

Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983;31:13-20.

Parker AS, Cerhan JR, Janney CA, Lynch CF, Cantor KP, et al. Smoking cessation and renal cell carcinoma. Ann Epidemiol. 2003;13:245-51.

Puşcaşiu D, Tatu C, Tatu RF, Potencz E, Popescu R, Muntean I, et al. The significance of angiogenesis and tumoral proliferation in renal cell carcinoma. Rom J Morphol Embryol. 2011;52:369-72.

Haitel A, Wiener HG, Migschitz B, Marberger M, Susani M. Proliferating Cell Nuclear Antigen and MIB-1 an alternative to classic prognostic indicators in Renal Cell Carcinomas? Am J Clin Pathol. 1997;107:229-35.

Baretton G, Kublmann B, Krech R, Lohrs U. Intratumoural heterogeneity of nuclear DNA-content and proliferation in clear cell type carcinomas of the kidney. Virchoius Arch B Cell Pathol. 1991;61:57-63.

Droz D, Zacher D, Charbit L, Gogusev J, Chr&tien Y, Lucien I. Expression of the human nephron differentiation molecules in renal cell carcinomas. Am J Pathol. 1990;137:895-905.

Kinouchi T, Saiki S, Naoe T, Uenaka A, Kotake T, Shiku H, et al. Correlation of c-myc expression with nuclear pleomorphism in human renal cell carcinoma. Cancer Res. 1989;49:3627-30.

de Riese WTW, Crabtree WN, Allhoff EP, Werner M, Liedke S, Lenis G, et al. Prognostic significance of Ki-67 immunostaining in non-metastatic renal cell carcinoma. J Cliri Oncol. 1993;ll:1804-8.

Morns GF, Mathews MB. Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Cheni. 1989;264:13856-64.